SEDAR Interim Financial Statements

[
  {
    "companyName": "Resverlogix Corp.",
    "reportingPeriodEnd": "2025-09-30",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cash": 64000,
      "prepaidExpensesAndDeposits": 141000,
      "investmentTaxCreditReceivable": 86000,
      "otherAssets": 58000,
      "clinicalSuppliesCurrent": 464000,
      "dueFromZenithCapitalCorp": 680000,
      "totalCurrentAssets": 1493000,
      "intangibleAssets": 2604000,
      "clinicalSuppliesNonCurrent": 3744000,
      "totalNonCurrentAssets": 6348000,
      "totalAssets": 7841000,
      "tradeAndOtherPayables": 17587000,
      "accruedInterest": 3834000,
      "promissoryNotesPayableToZenithCapitalCorp": 10572000,
      "otherPromissoryNotes": 765000,
      "leaseLiability": 42000,
      "warrantLiability": 576000,
      "debtCurrent": 8131000,
      "totalCurrentLiabilities": 41507000,
      "debtNonCurrent": 0,
      "otherLongTermLiability": 929000,
      "royaltyPreferredShares": 54300000,
      "totalLiabilities": 96736000,
      "shareCapital": 334900000,
      "contributedSurplus": 53828000,
      "deficit": -477623000,
      "totalShareholdersDeficiency": -88895000,
      "totalLiabilitiesAndShareholdersDeficiency": 7841000,
      "cashPerShare": 0.0002,
      "workingCapitalPerShare": -0.1407
    },
    "incomeStatement": {
      "threeMonths": {
        "2025": {
          "researchAndDevelopmentNetOfRecoveries": 722000,
          "investmentTaxCredits": -13000,
          "netResearchAndDevelopment": 709000,
          "generalAndAdministrativeNetOfRecoveries": 425000,
          "totalExpenses": 1134000,
          "lossGainOnChangeInFairValueOfWarrantLiability": 447000,
          "gainLossOnChangeInFairValueOfRoyaltyPreferredShares": -1800000,
          "gainOnChangeInFairValueOfDerivativeLiability": 0,
          "lossOnPayablesExtinguishment": 37000,
          "interestFeesAndAccretion": 1145000,
          "financingCosts": 0,
          "foreignExchangeGainLoss": -14000,
          "netFinanceIncomeCosts": -185000,
          "lossBeforeIncomeTaxes": 949000,
          "incomeTaxes": 2000,
          "netAndTotalComprehensiveLoss": 951000,
          "netLossPerShareBasicAndDiluted": 0.00
        },
        "2024": {
          "researchAndDevelopmentNetOfRecoveries": 721000,
          "investmentTaxCredits": -13000,
          "netResearchAndDevelopment": 708000,
          "generalAndAdministrativeNetOfRecoveries": 343000,
          "totalExpenses": 1051000,
          "lossGainOnChangeInFairValueOfWarrantLiability": 47000,
          "gainLossOnChangeInFairValueOfRoyaltyPreferredShares": 3000000,
          "gainOnChangeInFairValueOfDerivativeLiability": 0,
          "lossOnPayablesExtinguishment": 0,
          "interestFeesAndAccretion": 822000,
          "financingCosts": 0,
          "foreignExchangeGainLoss": 12000,
          "netFinanceIncomeCosts": 3881000,
          "lossBeforeIncomeTaxes": 4932000,
          "incomeTaxes": 3000,
          "netAndTotalComprehensiveLoss": 4935000,
          "netLossPerShareBasicAndDiluted": 0.02
        }
      },
      "nineMonths": {
        "2025": {
          "researchAndDevelopmentNetOfRecoveries": 2136000,
          "investmentTaxCredits": -37000,
          "netResearchAndDevelopment": 2099000,
          "generalAndAdministrativeNetOfRecoveries": 1431000,
          "totalExpenses": 3530000,
          "lossGainOnChangeInFairValueOfWarrantLiability": 387000,
          "gainLossOnChangeInFairValueOfRoyaltyPreferredShares": 500000,
          "gainOnChangeInFairValueOfDerivativeLiability": 0,
          "lossOnPayablesExtinguishment": 37000,
          "interestFeesAndAccretion": 3065000,
          "financingCosts": 0,
          "foreignExchangeGainLoss": 34000,
          "netFinanceIncomeCosts": 4023000,
          "lossBeforeIncomeTaxes": 7553000,
          "incomeTaxes": 8000,
          "netAndTotalComprehensiveLoss": 7561000,
          "netLossPerShareBasicAndDiluted": 0.03
        },
        "2024": {
          "researchAndDevelopmentNetOfRecoveries": 2018000,
          "investmentTaxCredits": -38000,
          "netResearchAndDevelopment": 1980000,
          "generalAndAdministrativeNetOfRecoveries": 1249000,
          "totalExpenses": 3229000,
          "lossGainOnChangeInFairValueOfWarrantLiability": -107000,
          "gainLossOnChangeInFairValueOfRoyaltyPreferredShares": 3000000,
          "gainOnChangeInFairValueOfDerivativeLiability": -239000,
          "lossOnPayablesExtinguishment": 0,
          "interestFeesAndAccretion": 2202000,
          "financingCosts": 16000,
          "foreignExchangeGainLoss": -7000,
          "netFinanceIncomeCosts": 4865000,
          "lossBeforeIncomeTaxes": 8094000,
          "incomeTaxes": 8000,
          "netAndTotalComprehensiveLoss": 8102000,
          "netLossPerShareBasicAndDiluted": 0.03
        }
      }
    },
    "cashFlowStatement": {
      "nineMonths": {
        "2025": {
          "netLoss": 7561000,
          "itemsNotInvolvingCash": {
            "equitySettledShareBasedPaymentTransactions": 329000,
            "depreciationAndAmortization": 317000,
            "lossGainOnChangeInFairValueOfWarrantLiability": 387000,
            "lossOnChangeInFairValueOfRoyaltyPreferredShares": 500000,
            "gainOnChangeInFairValueOfDerivativeLiability": 0,
            "lossOnExtinguishmentOfPayables": 37000,
            "unrealizedForeignExchange": 7000,
            "interestAndAccretion": 3065000,
            "netCurrentIncomeTaxes": 8000,
            "financingCosts": 0
          },
          "changesInNonCashWorkingCapital": {
            "prepaidExpensesAndDeposits": 21000,
            "investmentTaxCreditReceivable": -38000,
            "otherAssets": -18000,
            "clinicalSupplies": 107000,
            "dueFromZenithCapitalCorp": -487000,
            "tradeAndOtherPayables": 688000,
            "totalChangesInNonCashWorkingCapital": 2638000
          },
          "interestReceived": 1000,
          "incomeTaxPaid": -11000,
          "netCashUsedInOperatingActivities": -2648000,
          "proceedsFromPromissoryNotesPayable": 3034000,
          "financingCosts": 0,
          "changesInNonCashFinancingWorkingCapital": 0,
          "netCashProvidedByFinancingActivities": 3034000,
          "intangibleAssetAdditions": -434000,
          "changesInNonCashInvestingWorkingCapital": 11000,
          "netCashUsedInInvestingActivities": -423000,
          "effectOfForeignCurrencyTranslationOnCash": 2000,
          "decreaseIncreaseInCash": -35000,
          "cashBeginningOfPeriod": 99000,
          "cashEndOfPeriod": 64000
        },
        "2024": {
          "netLoss": 8102000,
          "itemsNotInvolvingCash": {
            "equitySettledShareBasedPaymentTransactions": 105000,
            "depreciationAndAmortization": 258000,
            "lossGainOnChangeInFairValueOfWarrantLiability": -107000,
            "lossOnChangeInFairValueOfRoyaltyPreferredShares": 3000000,
            "gainOnChangeInFairValueOfDerivativeLiability": -239000,
            "lossOnExtinguishmentOfPayables": 0,
            "unrealizedForeignExchange": -4000,
            "interestAndAccretion": 2202000,
            "netCurrentIncomeTaxes": 8000,
            "financingCosts": 16000
          },
          "changesInNonCashWorkingCapital": {
            "prepaidExpensesAndDeposits": -674000,
            "investmentTaxCreditReceivable": 20000,
            "otherAssets": -33000,
            "clinicalSupplies": -326000,
            "dueFromZenithCapitalCorp": -594000,
            "tradeAndOtherPayables": 981000,
            "totalChangesInNonCashWorkingCapital": 3489000
          },
          "interestReceived": 2000,
          "incomeTaxPaid": 0,
          "netCashUsedInOperatingActivities": -3487000,
          "proceedsFromPromissoryNotesPayable": 3795000,
          "financingCosts": -16000,
          "changesInNonCashFinancingWorkingCapital": -3000,
          "netCashProvidedByFinancingActivities": 3776000,
          "intangibleAssetAdditions": -395000,
          "changesInNonCashInvestingWorkingCapital": 144000,
          "netCashUsedInInvestingActivities": -251000,
          "effectOfForeignCurrencyTranslationOnCash": 0,
          "decreaseIncreaseInCash": 38000,
          "cashBeginningOfPeriod": 5000,
          "cashEndOfPeriod": 43000
        }
      }
    },
    "investmentsAndOtherAssets": [
      {
        "type": "Receivable",
        "description": "Due from Zenith Capital Corp. (related party)",
        "ownershipPercentage": null,
        "value": 680000,
        "notes": "Unsecured, payable on demand, non-interest bearing. Balance arises from management services and reimbursable expenses."
      }
    ],
    "shareStructure": {
      "authorizedShares": "unlimited",
      "issuedShares": 286964044,
      "classesOfShares": ["common", "royalty preferred"],
      "warrants": [
        {
          "number": 20912570,
          "exercisePrice": 0.20,
          "expiryDate": null
        }
      ],
      "options": [
        {
          "number": 2790000,
          "exercisePrice": 0.10,
          "expiryDate": null
        },
        {
          "number": 390000,
          "exercisePrice": 0.65,
          "expiryDate": null
        },
        {
          "number": 150000,
          "exercisePrice": 0.91,
          "expiryDate": null
        }
      ],
      "rightsConvertibleInstruments": null
    },
    "managementCompensation": {
      "currency": "USD",
      "periods": {
        "threeMonthsEnded2025-09-30": {
          "personnelCostsShortTermEmployeeBenefits": 539000,
          "shareBasedPaymentTransactions": 94000,
          "total": 633000
        },
        "nineMonthsEnded2025-09-30": {
          "personnelCostsShortTermEmployeeBenefits": 1767000,
          "shareBasedPaymentTransactions": 329000,
          "total": 2096000
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "Zenith Capital Corp.",
          "description": "Management and administrative services provided to Zenith, and reimbursable expenses (including proportionate share of rental and operating costs)",
          "amount": 520000,
          "period": "nine months ended 2025-09-30"
        },
        {
          "counterparty": "Zenith Capital Corp.",
          "description": "Promissory notes payable to Zenith (unsecured, 12% interest, payable within four months of demand)",
          "amount": 10572000,
          "period": "2025-09-30"
        },
        {
          "counterparty": "Zenith Capital Corp.",
          "description": "Due from Zenith (unsecured, payable on demand, non-interest bearing)",
          "amount": 680000,
          "period": "2025-09-30"
        }
      ]
    },
    "subsequentEvents": []
  }
]